A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Almotriptan
MRK-409
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with MRK-409.
Almotriptan
Cyclopropane
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Cyclopropane.
Almotriptan
N-(2-hydroxybenzyl)-2,5-dimethoxy-4-cyanophenylethylamine
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with N-(2-hydroxybenzyl)-2,5-dimethoxy-4-cyanophenylethylamine.
Almotriptan
2,5-Dimethoxy-4-ethylthioamphetamine
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with 2,5-Dimethoxy-4-ethylthioamphetamine.
Almotriptan
Brofaromine
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Brofaromine.
Almotriptan
Harmaline
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Harmaline.
Almotriptan
Lormetazepam
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Lormetazepam.
Almotriptan
Clopenthixol
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Clopenthixol.
Almotriptan
Doxefazepam
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Doxefazepam.
Almotriptan
Carbromal
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Carbromal.
Almotriptan
Reposal
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Reposal.
Almotriptan
Ethadione
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Ethadione.
Almotriptan
Penfluridol
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Penfluridol.
Almotriptan
Tilidine
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Tilidine.
Almotriptan
Dixyrazine
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Dixyrazine.
Almotriptan
Imipramine oxide
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Imipramine oxide.
Almotriptan
Vinylbital
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Vinylbital.
Almotriptan
Mephenoxalone
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Mephenoxalone.
Almotriptan
Fazadinium bromide
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Fazadinium bromide.
Almotriptan
Cyclobarbital
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Cyclobarbital.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3